David Vikstrom

David Vikstrom is currently the Deputy MD for Sweden and Pipeline and Portfolio Lead at Alvotech, focusing on biosimilar development. They completed their PhD in Biochemistry at Stockholm University, where their research centered on membrane protein biogenesis in E. coli. David served as Chief Technology Officer at Xbrane Biopharma AB and worked as a scientist at Xbrane Bioscience AB, where they specialized in vaccine development and strain engineering. They have been involved in various aspects of scientific research and development throughout their career.